Cutaneous Disorders in Crohn’s Disease Respond to Infliximab – (08-13-01)

Cutaneous Disorders in Crohn’s Disease Respond to Infliximab

This article supports things I’ve said for awhile now. Many chronic autoimmune conditions may actually come from the same basic metabolic defect, and that the ultimate manifestation of a certain disease is just a branch along the changes caused by the original defect. We are now seeing a drug (infliximab, a drug that blocks TNF alpha from doing it’s job) that is having an effect of rheumatoid arthritis, Crohn’s disease and now several autoimmune skin disorders as well. Before we get too excited here that the answer has been found, remember that TNF alpha is needed for healthy immune function and cancer prevention. I am sure that the long term use of these drugs will produce higher rates of certain types of cancer. Lowering levels of TNF naturally included weight loss, maintaining insulin sensitivity and leaning towards a plant based diet. Improvement of Pyoderma Gangrenosum and Psoriasis Associated With Crohn Disease With Anti-Tumor Necrosis Factor alpha Monocl

Read entire article here

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.